TRACON Pharmaceutical (TCON) Tops Q2 EPS by 15c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q2 EPS of ($0.24), $0.15 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $810 thousand.

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery